相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa
Laura Reyes-Uribe et al.
GUT (2021)
Effect of Aspirin on Cancer Incidence and Mortality in Older Adults
John J. McNeil et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Rapamycin Extends Life Span in ApcMin/+ Colon Cancer FAP Model
Manish Parihar et al.
CLINICAL COLORECTAL CANCER (2021)
Immune Activation in Mismatch Repair-Deficient Carcinogenesis: More Than Just Mutational Rate
Jason A. Willis et al.
CLINICAL CANCER RESEARCH (2020)
Prostaglandin E2 Induces miR675-5p to Promote Colorectal Tumor Metastasis via Modulation of p53 Expression
Bo Cen et al.
GASTROENTEROLOGY (2020)
Effect of Low-dose and Standard-dose Aspirin on PGE2 Biosynthesis Among Individuals with Colorectal Adenomas: A Randomized Clinical Trial
David A. Drew et al.
CANCER PREVENTION RESEARCH (2020)
Current Landscape of NRF2 Biomarkers in Clinical Trials
Yoko Yagishita et al.
ANTIOXIDANTS (2020)
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial
John Burn et al.
LANCET (2020)
Targeting Epigenetic 'Readers' with Natural Compounds for Cancer Interception
Elisabetta Damiani et al.
JOURNAL OF CANCER PREVENTION (2020)
A Novel Form of 4-1BBL Prevents Cancer Development via Nonspecific Activation of CD4+ T and Natural Killer Cells
Hampartsoum B. Barsoumian et al.
CANCER RESEARCH (2019)
Cancer Chemoprevention: Preclinical In Vivo Alternate Dosing Strategies to Reduce Drug Toxicities
Altaf Mohammed et al.
TOXICOLOGICAL SCIENCES (2019)
Dose-dependent detoxication of the airborne pollutant benzene in a randomized trial of broccoli sprout beverage in Qidong, China
Jian-Guo Chen et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2019)
Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma
Altaf Mohammed et al.
CANCER PREVENTION RESEARCH (2019)
Broccoli or Sulforaphane: Is It the Source or Dose That Matters?
Yoko Yagishita et al.
MOLECULES (2019)
Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator
Jing Pan et al.
EBIOMEDICINE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition
Praveen Rajendran et al.
CANCER RESEARCH (2019)
Identification of an Unfavorable Immune Signature in Advanced Lung Tumors from Nrf2-Deficient Mice
Di Zhang et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Role of prostanoids in gastrointestinal cancer
Dingzhi Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs
Adaobi Okonkwo et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2018)
The dawn of vaccines for cancer prevention
Olivera J. Finn
NATURE REVIEWS IMMUNOLOGY (2018)
Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo
Denise L. Cecil et al.
CLINICAL CANCER RESEARCH (2017)
Cancer prevention in the era of precision oncology
N. N. Brahme et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam
Furkan U. Ertem et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker et al.
LANCET (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
Jing Pan et al.
ONCOTARGET (2017)
Rexinoids for Prevention and Treatment of Cancer: Opportunities and Challenges
Karen T. Liby et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
The Immune System in Cancer Prevention, Development and Therapy
Serge M. Candeias et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
Development of a murine colonoscopic polypectomy model (with videos)
Furkan Ertem et al.
GASTROINTESTINAL ENDOSCOPY (2016)
Thymic stromal lymphopoietin blocks early stages of breast carcinogenesis
Shadmehr Demehri et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Immunologic approaches to cancer prevention-current status, challenges, and future perspectives
Malgorzata E. Wojtowicz et al.
SEMINARS IN ONCOLOGY (2016)
Molecular Cancer Prevention: Current Status and Future Directions
Karen Colbert Maresso et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
SAS Macro for Causal Mediation Analysis with Survival Data
Linda Valeri et al.
EPIDEMIOLOGY (2015)
eRapa Restores a Normal Life Span in a FAP Mouse Model
Paul Hasty et al.
CANCER PREVENTION RESEARCH (2014)
Rapid and Sustainable Detoxication of Airborne Pollutants by Broccoli Sprout Beverage: Results of a Randomized Clinical Trial in China
Patricia A. Egner et al.
CANCER PREVENTION RESEARCH (2014)
Elimination of IL-10-Inducing T-Helper Epitopes from an IGFBP-2 Vaccine Ensures Potent Antitumor Activity
Denise L. Cecil et al.
CANCER RESEARCH (2014)
Identification of Putative Immunologic Targets for Colon Cancer Prevention Based on Conserved Gene Upregulation from Preinvasive to Malignant Lesions
Elizabeth K. Broussard et al.
CANCER PREVENTION RESEARCH (2013)
Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease
Karen T. Liby et al.
PHARMACOLOGICAL REVIEWS (2012)
An Msh2 Conditional Knockout Mouse for Studying Intestinal Cancer and Testing Anticancer Agents
Melanie Kucherlapati et al.
GASTROENTEROLOGY (2010)
Costimulation as a Platform for the Development of Vaccines: A Peptide-Based Vaccine Containing a Novel Form of 4-1BB Ligand Eradicates Established Tumors
Rajesh K. Sharma et al.
CANCER RESEARCH (2009)
A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity
Rich-Henry Schabowsky et al.
VACCINE (2009)
A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer
James M. Amos-Landgraf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
分享论文
